Published in Endocrinology on December 28, 2006
Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis. World J Gastroenterol (2013) 0.83
Expression, binding, and signaling properties of CRF2(a) receptors endogenously expressed in human retinoblastoma Y79 cells: passage-dependent regulation of functional receptors. J Neurochem (2007) 0.81
Distribution of urocortins and corticotropin-releasing factor receptors in the cardiovascular system. Int J Endocrinol (2012) 0.80
Diminished expression of CRHR2 in human colon cancer promotes tumor growth and EMT via persistent IL-6/Stat3 signaling. Cell Mol Gastroenterol Hepatol (2015) 0.80
Development of adrenal cortex zonation. Endocrinol Metab Clin North Am (2015) 0.80
Maternal high-fat diet and obesity impact palatable food intake and dopamine signaling in nonhuman primate offspring. Obesity (Silver Spring) (2015) 0.78
Maternal exposure to low levels of corticosterone during lactation protects against experimental inflammatory colitis-induced damage in adult rat offspring. PLoS One (2014) 0.76
Urocortin 2 lowers blood pressure and reduces plasma catecholamine levels in mice with hyperadrenergic activity. Endocrinology (2010) 0.76
Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science (1981) 9.64
TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell (2000) 6.07
Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin. EMBO J (1988) 3.26
Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature (1982) 2.44
Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature (1986) 2.29
Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci (1999) 2.20
Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet (2000) 1.90
Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res (1983) 1.86
Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci U S A (1981) 1.78
Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med (2000) 1.72
Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc Natl Acad Sci U S A (1988) 1.70
Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology (1982) 1.58
Characterization of rat hypothalamic corticotropin-releasing factor. Proc Natl Acad Sci U S A (1983) 1.58
Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation. Genes Dev (1997) 1.57
Strain and substrain differences in context- and tone-dependent fear conditioning of inbred mice. Behav Brain Res (1999) 1.53
Increased levels of lipoprotein (a) in Crohn's disease: a relation to thrombosis? Eur J Gastroenterol Hepatol (2001) 1.50
Relationship between fos production and classical fear conditioning: effects of novelty, latent inhibition, and unconditioned stimulus preexposure. J Neurosci (1998) 1.49
Production of an epidermal growth factor receptor-related protein. Science (1984) 1.46
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. Eur J Clin Pharmacol (2011) 1.43
Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review. Cancer Gene Ther (2012) 1.41
Malpractice issues in modern anaesthesiology. Eur J Anaesthesiol (2007) 1.38
Phosphorylated cAMP response element binding protein in the mouse brain after fear conditioning: relationship to Fos production. Brain Res Mol Brain Res (2001) 1.37
Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides. Proc Natl Acad Sci U S A (1987) 1.37
Isolation and sequence analysis of a somatostatin-like polypeptide from ovine hypothalamus. Biochemistry (1981) 1.35
Production of the Fos protein after contextual fear conditioning of C57BL/6N mice. Brain Res (1998) 1.34
Isolation and characterization of somatostatin from pigeon pancreas. Proc Natl Acad Sci U S A (1979) 1.34
In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology (1982) 1.32
Purification and partial characterization of inhibin from porcine follicular fluid. Biochem Biophys Res Commun (1985) 1.27
Characterization of a teleost gonadotropin-releasing hormone. Proc Natl Acad Sci U S A (1983) 1.26
Characterization of rat hypothalamic growth hormone-releasing factor. Nature (1983) 1.24
Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man. Lancet (1983) 1.23
Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30. Proc Natl Acad Sci U S A (1998) 1.23
Evidence for the existence of a biosynthetic precursor for somatostatin. Diabetes (1979) 1.22
Generalization of fear responses in C57BL/6N mice subjected to one-trial foreground contextual fear conditioning. Behav Brain Res (1998) 1.19
Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats. Endocrinology (1982) 1.19
Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metab Res (2007) 1.18
Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat Immunol (2001) 1.16
Inhibin A-subunit cDNAs from porcine ovary and human placenta. Proc Natl Acad Sci U S A (1986) 1.16
Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. J Clin Invest (1983) 1.14
Urocortin in human gastric mucosa: relationship to inflammatory activity. J Clin Endocrinol Metab (2003) 1.10
Retracted NCL-CD30 staining of epithelial cells in the basal germinative layer of the epidermis and epithelial buds during foetal skin development. Clin Exp Med (2005) 1.09
Hepatocyte swelling leads to rapid decrease of the G-/total actin ratio and increases actin mRNA levels. FEBS Lett (1992) 1.09
Stress-induced alternative splicing of acetylcholinesterase results in enhanced fear memory and long-term potentiation. Mol Psychiatry (2004) 1.08
Immunoreactive corticotropin-releasing factor is present in human maternal plasma during the third trimester of pregnancy. J Clin Endocrinol Metab (1984) 1.07
Phosphorylation of high mobility group protein 14 by casein kinase II. J Biol Chem (1985) 1.07
Differences in the G/total actin ratio and microfilament stability between normal and malignant human keratinocytes. Cell Biochem Funct (1994) 1.07
Overexpression of the Tpl-2/Cot oncogene in human breast cancer. Oncogene (1999) 1.06
Corticotropin-releasing factor: effects on the sympathetic nervous system and oxygen consumption. Life Sci (1982) 1.03
Effect of tone-dependent fear conditioning on heart rate and behavior of C57BL/6N mice. Behav Neurosci (1997) 1.03
Primary gastric Hodgkin's lymphoma: a case report and review of the literature. Leuk Lymphoma (2005) 1.02
Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding. J Neurochem (1999) 1.01
The maternal hypothalamic-pituitary-adrenal axis in the third trimester of human pregnancy. Clin Endocrinol (Oxf) (1996) 1.01
Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretion in vitro. Endocrinology (1983) 1.01
Cytochalasin B may shorten actin filaments by a mechanism independent of barbed end capping. Biochem Pharmacol (1994) 1.01
Differential impairment of auditory and contextual fear conditioning by protein synthesis inhibition in C57BL/6N mice. Behav Neurosci (1999) 1.01
Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Maturitas (2004) 1.01
Patterns of male-specific inter-population divergence in Europe, West Asia and North Africa. Ann Hum Genet (2000) 1.00
Molecular pathogenesis of pancreatic cancer and clinical perspectives. Oncology (2011) 1.00
Altered actin polymerization dynamics in various malignant cell types: evidence for differential sensitivity to cytochalasin B. Biochem Pharmacol (1996) 1.00
Serotonin 5-HT2 receptor activation potentiates N-methyl-D-aspartate receptor-mediated ion currents by a protein kinase C-dependent mechanism. J Neurosci Res (1996) 0.99
Multiple forms of somatostatin-like activity in rat hypothalamus. Biochemistry (1980) 0.98
Characterization of native corticotropin-releasing factor receptor type 1 (CRFR1) in the rat and mouse central nervous system. J Neurosci Res (1998) 0.98
Expression of HLA-DR antigen and characterization of the lymphocytic infiltrate in normal mucosa, tubulo-villous adenoma and invasive carcinoma of the colon. Chirurgia (Bucur) (2005) 0.97
The position of the axillary nerve in the deltoid muscle. A cadaveric study. Acta Orthop Scand (1999) 0.96
Primary structure and functional expression of a glutaminyl cyclase. Proc Natl Acad Sci U S A (1991) 0.96
The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses. Proc Natl Acad Sci U S A (1997) 0.96
Post-training injections of catecholaminergic drugs do not modulate fear conditioning in rats and mice. Neurosci Lett (2001) 0.95
Investigation of larger forms of somatostatin in pigeon pancreas and rat brain. Metabolism (1978) 0.95
Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery. J Clin Endocrinol Metab (1987) 0.95
Pharmacology and biology of corticotropin-releasing factor (CRF) receptors. Receptors Channels (2002) 0.95
The corticotropin releasing hormone gene is expressed in human placenta. Biochem Biophys Res Commun (1987) 0.95
Involvement of the 5-HT1A receptors in classical fear conditioning in C57BL/6J mice. J Neurosci (2000) 0.95
Prevalence of polyps and diverticulosis of the large bowel in the Cretan population. An autopsy study. Int J Colorectal Dis (2001) 0.95
Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor. J Clin Endocrinol Metab (1982) 0.94
Immature malignant sacrococcygeal teratoma: case report and review of the literature. Clin Exp Obstet Gynecol (2013) 0.94
Maternal serum corticotropin-releasing hormone and ACTH levels as predictive markers of premature labor. Int J Gynaecol Obstet (2007) 0.93
Sequence analysis of a growth hormone releasing factor from a human pancreatic islet tumor. Biochemistry (1982) 0.93
Comparison of the biologic actions of corticotropin-releasing factor and sauvagine. Regul Pept (1982) 0.93
Effect of hepatocyte swelling on microtubule stability and tubulin mRNA levels. Biochem Cell Biol (1994) 0.93
Isolation and characterization of somatostatin from anglerfish pancreatic islet. Endocrinology (1979) 0.93
Primary structure and tissue distribution of anglerfish carboxypeptidase H. Mol Cell Endocrinol (1991) 0.93
Regulation of endometrial cancer cell growth by luteinizing hormone (LH) and follicle stimulating hormone (FSH). Br J Cancer (2000) 0.92
Inhibition of corticotropin releasing hormone type-1 receptor translation by an upstream AUG triplet in the 5' untranslated region. Mol Pharmacol (2001) 0.92
High grade primary adrenal intravascular large B-cell lymphoma manifesting as Addison disease. Rev Esp Enferm Dig (2007) 0.91
Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami. Peptides (1989) 0.91
Phagocytosis of Escherichia coli by insect hemocytes requires both activation of the Ras/mitogen-activated protein kinase signal transduction pathway for attachment and beta3 integrin for internalization. J Biol Chem (1998) 0.91
Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron (1995) 0.91
Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1. Protein Sci (2001) 0.91
Normal ras genes: their onco-suppressor and pro-apoptotic functions (review). Int J Oncol (2002) 0.91
Myxoid liposarcoma of the spermatic cord: a case report and review of the literature. Int Urol Nephrol (2003) 0.91
Evidence fore biosynthesis and differential post-translational proteolytic processing of different (pre)prosomatostatins in pancreatic islets. J Biol Chem (1983) 0.91
Association between H1N1 infection severity and obesity-adiponectin as a potential etiologic factor. J Infect Dis (2010) 0.90
Isolation and characterization of a corticotropin-releasing hormone-like peptide from human placenta. J Clin Endocrinol Metab (1988) 0.90
B7H4, HSP27 and DJ-1 molecular markers as prognostic factors in pancreatic cancer. Pancreatology (2013) 0.89